“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P1.16 Cutaneous involvement and linear IgA dermatosis in a patient with angioimmunoblastic T-cell lymphoma

€3.03

SKU: product-article-18341 Category: General

Description

Description

P1.16 Cutaneous involvement and linear IgA dermatosis in a patient with angioimmunoblastic T-cell lymphoma

Top

Article: P1.16 Cutaneous involvement and linear IgA dermatosis in a patient with angioimmunoblastic T-cell lymphoma

Description

Related products

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in breast cancer

Article: Calendar of events

1 year subscription print edition of the Belgian Journal of Hematology (BJH)